As reported previously in human monocytes, a human lung epithelial cell line, A549, showed de novo induction of 15-Lipoxygenase-1 (15-LO-1) in response to interleukins-13 (IL-13) and −4 (IL-4). In this cell line, 15-LO-1 expression, by RT-PCR and western blotting, was observed following 6 and 24 h of exposure to human IL-13 (ED 50 5 ng/ml) and IL-4 (ED 50 0.2 ng/ml). We have previously shown that no cis-acting regulatory elements exist within the 15-LO-1 promoter region. To define IL-13 and IL-4 responsive trans-acting elements, we identified a region (DP2: −353 to −304 bp site) within the 15-LO-1 promoter (by footprinting experiments) to which IL-13-responsive elements (or factors) bind specifically (Kelavkar et al, 1998, Mol Biol Rep 25, 173-182). To further delineate this region, we constructed (by site-directed mutagenesis) several deletion mutants in the 'LOPB5' region containing the 29 bp within the −353 to −304 bp of the DP2 core element. These were: DP3 (site totally deleted), DP4 (5 bp deleted at the center of the site), DP5 (8 bp at the 5Ј-end of the site) and DP6 (13 bp at the 3Ј-end of the site). Cotransfection of these deletion constructs (driving luciferase reporter genes) was associated with 90% (DP4, DP5 and DP6) or 100% (DP3) abrogation of promoter activity at 24 h. Purification of nuclear protein extracts from IL-13 and IL-4-stimulated A549 cells, using a DP2 core containing affinity column, identified a 150 kDa protein under non-denaturing conditions, and two, 70 and 85 kDa proteins under denaturing conditions. These were not detectable by Coomassie blue staining in control nuclear protein extracts. Matrix assisted laser desorption ionization mass spectrometry (MALDI-MS) of the tryptic digests of these proteins, identified one as the 86 kDA Lupus KU autoantigen protein P86 and the second as the 70 kDa Lupus KU autoantigen protein P70. Gel shift and supershift experiments using monoclonal antibodies toward Ku antigen and its individual subunits, and utilizing DP2 and other mutant oligonucleotides with purified nuclear protein extracts from control and cytokine-treated A549 cells, confirmed our findings. Furthermore, electroporation of neutralizing anti-Ku70, Ku 80 and Ku70/80 antibodies into A549 cells totally suppressed IL-13 and IL-4-stimulated 15-LO-1 induction in these cells. Further, immunoprecipitation experiments data suggests that IL-4 and IL-13 activate Ku antigens and 15-LO-1 expression through distinct signaling events. In summary, in A549 cells, Ku antigen is induced in response to the cytokines, IL-13 and −4, and a 29 bp region within the −353 to −304 bp region of the 15-LO-1 promoter is required for its binding and subsequent induction of 15-LO-1 gene expression. The findings may provide an important link between the established dysregulated function of Ku antigen in auto-immune diseases, such as systemic lupus erythematosus and thyroiditis, and the increasingly recognized 'anti-inflammatory' role of 15-LO-1. Genes and Immunity (2000) 1, 237-250.
Introduction
Cytokines mediate their pleiotropic effects on cells by binding to specific transmembrane-spanning receptors, whose activation often results in the induction of new genes. Characterization of the ability of IFN-␥ and interleukin-4 (IL-4) to rapidly induce new genes has led to the elucidation of the JAK-STAT (signal transducer and activator of transcription) signaling pathway, which is now known to transduce signals for other cytokines as well. [1] [2] [3] Interleukin (IL)-13 and −4 are cytokine products of TH2 cells which exert similar profiles of biological activation in a variety of cell types. Like IL-4, IL-13 is a regulator of human B cell and monocyte functions. 4 Recently Yu et al 5 demonstrated that IL-13 induces distinct STAT6-DNA binding complexes and tyrosine phosphorylation of STAT6 and Janus kinase 3 (JAK3) in NK and T cells. Curiel et al 6 have identified a Stat-6-responsive element (Stat-6RE) in the promoter of the human IL-4 gene, as well as two specific IL-4 responsive DNA-protein complexes in nuclear extracts of both human Th1 and Th2 clones. Their results indicate a possible autocrine mechanism for the regulation of IL-4 gene transcription through Stat-6RE, as well as a possible mechanism for IL-13 regulation of the human IL-4 promoter. Several studies have reported that both IL-4 and IL-13 share common signaling events, such as those observed in human colon carcinoma cell lines HT-29 and WiDr. 7, 8 These studies demonstrate that a single cytokine can activate different combinations of Stat proteins under different physiological conditions, and also indicate mechanisms by which distinct cytokines can activate the same Stat protein.
IL-4 was the only cytokine known to induce 15-Lipoxygenase-1 (15-LO-1) in human monocytes/ macrophages. 9, 10 We demonstrated that IL-13 also induces 15-LO-1 mRNA and protein synthesis in those cells leading to enhanced production of 15-(S)-HETE. 11 These effects were inhibited by IFN-␥, as was seen in IL-4-induced 15-LO-1 expression. 10 Similar results have been observed by Brinkmann et al. 12 in a human epithelial cell line, A549 in which induction of 15-LO-1 by IL-13 and IL-4 was demonstrated.
Arachidonate 15-Lipoxygenase-1 (arachidonate:oxygen 15-oxidoreductase, EC 1.13.11.33) (15-LO-1) is implicated in oxidizing arachidonic acid and low-density lipoprotein, reactions of potential relevance to inflammation, membrane remodeling and atherosclerosis. 13 Recently, we have demonstrated regulation of 15-LO-1 gene expression by the mutant form of p53 tumor suppressor protein.
14 Formation of 15-(S)-hydroxyeicosatetraenoic acid (15-(S)-HETE) and lipoxin (LX) A4 in human leukocytes, mediated by 15-LO-1 dependent catalysis of arachidonic acid, likely represents a component of endogenous anti-inflammatory influences that ultimately regulate the extent and severity of inflammatory reaction. 15 In order to study the transcriptional control of 15-LO-1 expression, we have previously cloned and sequenced the human 15-LO-1 promoter region. 16 We have also shown that there are no STAT binding DNA sequences in this promoter, and that no cis-acting elements could account for the upregulation of 15-LO-1 expression. 13 We therefore sought to isolate the transcription factor/s that is/are induced in response to IL-13 and 4 respectively, and which lead to 15-LO-1 expression in human cells. The usefulness of freshly obtained human monocytes for addressing mechanistic questions of 15-LO-1 expression at the molecular level is limited by the biological variability of these cells, and their relative resistance to transfection. To circumvent this problem, we performed studies in the permanent human epithelial cell line A549 which expresses IL-13 and IL-4 receptors, as described by Brinckmann et al. 12 In this paper, we report the isolation of a transcription factor for IL-13/IL-4 induction of 15-LO-1, namely Kuautoantigen 70/80. This is an abundant acidic nuclear protein first identified in sera from patients with polymyositis-scleroderma overlap syndrome. It belongs to a family of proteins known to play a critical role in mammalian DNA double-strand break repair and lymphoid V(D)J recombination, which includes the autoantigens Ku86 and Ku70 and the 465 kDa serine/threonine protein kinase catalytic subunits (DNA-PKcs). The DNA-dependent protein kinase (DNA-PK) is a trimeric enzyme consisting of a 460 kDa catalytic subunit (DNA-PKcs) and a heterodimeric regulatory complex called Ku (also defined as ATP-dependent-DNA helicase), which is comprised of 70 (Ku70) and 86 (Ku80) kDa subunits. These proteins physically associate to form a complex (DNA-PK) with DNA-dependent protein kinase activity. DNA-PKcs also phosphorylate several nuclear DNA-binding regulatory transcription factor proteins (eg, Sp1 and p53), which suggests that DNA-PKcs may play a role in regulating transcription, replication, recombination as well as DNA repair. 17, 18 We have also shown by site-directed mutagenesis (creating mutant DP2 plasmids), gel-shift, and transfection experiments, that the entire 29 bp region within the −353 to −304 bp (+1 is adenine in the ATG start codon) region of the 15-LO-1 promoter is required for the binding of Ku-autoantigen 70/80 and that this DNA binding protein/factor is responsible for cytokineinduced upregulation of 15-LO-1 in A549 cells.
Results

Purification and identification of the 15-LO-1 promoter core binding proteins in human A549 cells
We previously identified a protein/s binding region (DP2) of the 15-LO-1 promoter by footprinting and gel retardation studies in HeLa cells and human monocytes. 16 In order to purify and identify these IL-13 and -4 responsive elements in human A549 cells, we prepared proteins from whole-cell extracts of cells grown in control and experimental conditions and examined the extracts for protein binding to the DP2 core element. The proteins were purified by affinity chromatography using biotin labeled double-stranded oligonucleotides immobilized on streptavidin-coated Dynabeads (DP2-DNA affinity chromatography).
Briefly, proteins from whole-cell extracts of A549 (control and experimentally grown) were prepared from cells, added to an eppendorf tube containing biotin labeled double-stranded oligonucleotides immobilized on streptavidin-coated Dynabeads and then eluted as described in the scheme of Figure 1b . Proteins specifically recognizing the DP2 core sequence were finally purified from the crude proteins from whole-cell extracts. The individually purified proteins were then analyzed by gel electrophoresis, followed by either Coomassie blue staining and/or Western blotting. By SDS-gel electrophoresis (denaturing), two bands due to 70 and 85 kDa proteins were detectable, but none at 150 kDa ( Figure 1c , lanes 4 and 5). Under native conditions without SDS, on the other hand, a single band was detected at approximately 150 kDa (data not shown). The results suggest that the 70 and 85 kDa proteins exist in dimeric forms in the absence of denaturing reagents. The binding specificity of the purified proteins was then verified by competition experiments as described later in the section. To identify these proteins, mass-spectrometry on the proteolytic digest was carried out at the biotechnology resource laboratory at Yale University, CT. The primary program used for identification carried out a PeptideSearch algorithm using European Molecular Biology (EMBL)/nonredundant database. The criteria used were: (1) matching of peptide masses to Ͼ25% of the predicted protein sequence using a mass tolerance of ±0.2 amu for monoisotopic and ± 0.5 amu for observed masses; and (2) PeptideSearch probability of 1.0 e+00. These analyses of the results suggest strongly that the protein purified as DP2 core binding protein is Ku antigen.
In further experiments, the purified DP2 core binding proteins were blotted onto a PVDF membrane and then reacted with a mixture of two different anti-Ku antigen Total proteins from whole cell extracts of control (no cytokine added) cells. Lane 2: Total proteins from whole cell extracts of IL-4 induced cells. Lane 3: Total proteins from whole cell extracts of IL-13 induced cells. Lane 4: DP2 bound proteins from step 4 (described in Figure  1 (b) eluted from whole cell extracts of IL-4 induced cells. Lane 5: DP2 bound proteins from step 4 (described in Figure 1 (b) eluted from whole cell extracts of IL-13 induced cells. Lane 6: DP2 bound proteins from step 4 (described in (b)) eluted from whole cell extracts of IL-13 induced cells. Lane 6: DP2 bound proteins from step 4 (described in (b)) eluted from nuclear extracts of control cells. Lane 7: Supernatant (unbound to DP2) of proteins from step 4 (described in (b)) from whole cell extracts of control cells. Lane 8: Supernatant (unbound to DP2) of proteins from step 4 (described in (b)) whole cell extracts of IL-4 induced cells. Lane 9: Supernatant (unbound to DP2) of proteins from step 4 (described in (b)) from whole cell extracts of IL-13 induced cells. Arrows indicate specific bands.
antisera, Ku70 and Ku80 respectively. The DP2 core binding proteins showed bands at 70 and 85 kDa (data not shown). However, the immunoprecipitation also shows the presence of Ku70 and Ku80 in control grown cells, suggesting that these proteins are constitutively expressed in A549 cells, and is likely that Ku is present in both stimulated and unstimulated cells, but that stimulation of the cells with IL-4 or -13 alters the DNA binding properties of Ku. This property allows the protein to bind to DNA, hence be purified by affinity chromatography thus levels undetectable by Coomassie blue staining. By densitometric scanning of Western blots of immunoprecipitated proteins by mixture of anti-Ku70, -Ku80 andKu70/80 antibody indicate a two to three-fold increased expression of these proteins. These results indicated that the purified DP2 core binding proteins of 70 and 85 kDa were expressed in response to cytokines and are immunologically indistinguishable from the p70 and p80 subunits of Ku antigen.
In our earlier studies with 15-LO-1 promoter in HeLa cells and monocytes, inhibition of DP2-protein binding was observed with excess amounts of competitor oligonucleotide sequences homologous to the probes, whereas no inhibition was seen in the presence of the non-specific oligonucleotide TGF␤. 16 The proteins purified from A549 cells were thus good candidates for specific recognition of the DP2 core of the 15-LO-1 promoter sequence. Gel-shift assays with purified nuclear extracts and 32 Plabeled double-stranded (ds) DP2 probe as described in 'Experimental procedures', confirmed the binding of Ku. Three bands along with non-specific protein-DNA complexes (NS) were formed on the DP2 when the gel shift experiments are conducted with IL-4 or -13 stimulated extracts that bind to the probe specifically, as characterized by a competition with an excess of cold probe. Non-specific binding was significantly competed in the presence of an excess amount of non-labeled oligonucleotide with the same sequence as the probe (Figure 2a) . Two of the bands are super-shifted by anti-Ku antibodies, the slowest migrating band completely, and to a lesser extent the middle band. The fastest migrating band does not appear to be super-shifted by the antibody. This argues that there may be two DNA protein complexes that contain Ku, while the slowest migrating and most plentiful complex contains a protein that co-purifies with the Ku proteins. Therefore, even though the complexes that formed on the DNA in the presence and absence of IL-4/13 appear to be of similar size and intensity, they are distinct.
Ku did not bind to ds DP3 (DP2 site totally deleted) (Figure 2b ). These results indicated that protein which specifically recognized the DP2 core sequence exists in A549 cells, similar to one described by us previously. Site-directed mutagenesis and promoter analysis of DP2 and its derivatives To delineate the identity and ascertain the specificity of discreet sequences in LOPB5 containing the DP2 region within the 15-LO-1 promoter, which are responsible for Ku binding, several deletion mutant plasmids, namely DP3 (site totally deleted), DP4 (5 bp deleted at the center of the site), DP5 (8 bp at the 5Ј-end of the site) and DP6 (13 bp at the 3Ј-end of the site) were constructed by sitedirected mutagenesis. Co-transfections of these mutant constructs (driving luciferase reporter genes) into A549 cells grown in control and experimental conditions yielded the following: DP3 completely lost its promoter activity. With the other mutants, almost 90% promoter activity in experimental conditions was abrogated when compared to LOPB5 ( Table 1) .
Binding of DP2 and mutant derivatives to Ku
Gel-shift experiments, using labeled ds DP2 oligonucleotide (and other mutants described previously) with purified protein extracts of control and experimentally grown A549 cells indicate that DP2-binding proteins are induced only in response to IL-13 and IL-4 treatments and bind, albeit weakly, to other mutants, except DP3 ( Figure 3 ). Of note, during the initial purification procedure (described above), nuclear extracts were preeluted over streptavidin beads conjugated with DP3 (completely deleted DP2) to remove non-specific binding proteins, and subsequently, the unbound proteins were added to the streptavidin beads conjugated with DP2 ( Figure 1a) . Further, the proteins that bound to DP3 did not contain Ku antigen as assessed by Western blotting (data not shown). These observations clearly indicate that the target proteins do not bind non-specifically to oligonucleotide ends, as proposed by others. 16 To further confirm that the purified protein indeed directly bound to the respective oligonucleotides, data of super-shift assay using monoclonal anti-Ku70 antibody is shown in this paper (Data with anti-Ku80 and anti-Ku70/80 show identical data and hence not shown). Protein binding to DP2 oligonucleotide was near-abolished by antibody addition, indicating that the DP2 core sequence was bound directly by the purified protein, ie Ku antigen. The purified DP2 binding proteins that reacted with anti-Ku antibodies were subjected to the supershift assays with the labeled DP2 and its mutant derivative core oligonucleotides (Figure 3a-d ). These complexes of DP2 and its mutant derivatives with the binding proteins were abolished by pretreatment with either anti-Ku antiserum. Also, pretreatment of these proteins with non-specific anti-hamster mouse IgG 1 control antibody, affected neither complex formation nor gel migration. Our data suggest that while Ku does bind to the 15-LO-1 promoter in a sequence-specific manner, other proteins that are regulated by IL-4 and -13 do as well. The analysis with gel shift conducted with the deletion mutants as probes indicate clearly that DP3 does not bind to the same proteins. When DP4 is used as a probe the pattern is similar to the pattern seen with the DP2 probe. However, when DP5 and DP6 are used as probes, the control extract and the DP5 probe have the same pattern as the DP2 probe, but when IL-4/13 extracts are used the NS complex is not formed. The NS complex re-appears when the antiKu antibodies are added and the S complex is supershifted. This suggests that there is a competition between the proteins for DNA binding. The pattern obtained with the DP6 probe is particularly interesting since the NS complex does not form on this DNA sequence, arguing that the sequences that are required for binding of this protein are deleted in this probe. Super-shifts were observed with all the ds oligonucleotitides. These observations could be explained by three possibilities: (1) examining the studies with DP5 (mutated region TACACACG) and DP6 (mutated region ACTCCTACCC) ( Ku70/80 complex may not be essential for DNA binding; and (3) Ku70 or Ku80 could individually bind to DNA independent of each other. However, our data with DP2 and its mutant plasmid transfections (Table 1) and with the anti-Ku antibody electroporation studies described below, strongly suggest that Ku70/80 complex binding to the DP2 (15-LO-1 promoter region) is essential for 15-LO-1 transcription, although the precise characterization or roles of individual Ku's in gene transcription is still unexplored and remains to be studied. These results further confirm that: (1) the protein responsible for DP2 core binding is sequence specific; and (2) it is, or contains, Ku antigen. Taken together these observations suggest that the entire 29-bp region within the −353 to −304 bp region of the 15-LO-1 promoter within DP2 is required specifically for Ku binding.
Radiolabeling and immunoprecipitation of Ku antigens
To examine potential differences in the cellular actions of both cytokines, to determine the turn-over and stability of Ku and the possibility of any other protein binding to Ku, cells were radiolabeled with [ analyzed by SDS-electrophoresis. As seen in Figures 4b, 5b and 6b, lanes 4-6 (cyclohexamide-treated), compared to Figures 4b, 5b and 6b, lanes 1-3 (cyclohexamideuntreated) , there seems to be a rapid turnover of Ku antigen, because the levels of these proteins as analyzed by SDS-electrophoresis seem to be steady (Figures 4a, 5a and  6a) . In a different set of experiments, we analyzed by densitometric scanning the Western blots of immunoprecipitated proteins by mixture of anti-Ku70, -Ku80 and -Ku70/80 antibody. The values indicate a two to threefold increased expression of these proteins in stimulated, compared to unstimulated, cells (data not shown). Also there were two slow migrating proteins that coimmunoprecipitated with the anti-Ku70 and -Ku70/80 (Figures 4a and 6a ), while only a single protein in the lower levels were detectable by anti-Ku80 (Figure 5a ). We have not identified and characterized these proteins so far. 
Discussion
Arachidonate 15-LO-1 is implicated in oxidizing arachidonic acid, membrane lipids and low-density lipoprotein, reactions of potential relevance to inflammation, membrane remodeling and atherosclerosis. 13 Recently, we have demonstrated regulation of 15-LO-1 gene expression by the mutant form of p53 tumor suppressor protein.
14 IL-13, a cytokine similar to IL-4, is a regulator of human B cell and monocyte functions, and stimulates formation of 15-(S)-hydroxyeicosatetraenoic acid (15-(S)-HETE) and lipoxin (LX) A4 in human monocytes via specific de novo induction of gene expression. 11 The IL-13 and -4 dependent 15-LO-1 expression likely represents a component of endogenous anti-inflammatory influences that ultimately regulate the extent and severity of inflammatory reactions. 15 In order to study the transcriptional control of 15-LO-1 expression by IL-13 and -4, we previously cloned and sequenced the human 15-LO-1 promoter region. 16 Brinkmann et al 12 
demonstrated induction of 15-LO-1 by IL-13 and IL-4 in human epithelial cells A549.
In the present study, we describe the purification and functional analyses of the 15-LO-1 promoter DNA binding proteins present in human A549 cells exposed to IL-13 and -4. A DNA affinity column containing the DP2 core element identified two proteins of 70 and 85 kDa (Figure 1c) . The profiles of the purified proteins on polyacrylamide gels under denaturing and non-denaturing conditions, suggested that the 70 and 85 kDa proteins are heterodimers. In addition to heterodimer formation, the 70 and 85 kDa proteins we identified were immunologically indistinguishable from Ku antigen, and the interaction of the proteins with the DP2 core sequence was specific by super-shift assays with the addition of anti-Ku antibodies (Figure 3) .
Our data showed no difference in the proteolytic digest patterns of the DP2 core binding protein and standard Ku antigen (data obtained from biotechnology resource laboratory at Yale University, CT and not shown).
Ku autoantigen is present in cell nuclei and cytoplasm and is known to have DNA binding activity. Our data with A549 cells also suggests that 15-LO-1 expression may also be regulated, at least in part, through changes in the nuclear expression of Ku. Recently, the roles and functions of Ku protein and its DNA-dependent protein kinase catalytic subunit (helicase) with nucleic acids have been reviewed. 18 Here, we provide evidence that Ku binds to the DP2 core region of the 15-LO-1 promoter and is induced in response to IL-13 and IL-4. The cDNAs for subunits, Ku-p70 and Ku-p80, have been cloned 20, 21 and shown to be similar to Human DNA helicase II. 22 Ku has been shown to phosphorylate several proteins that regulate transcription. 23, 24 Our findings by purification experiments (Figure 1b) , gel-shift analysis (Figures 2 and 3 ), plasmid transfections (Table 1) , and electroporation data (Figure 7 ) are some- what at variance with those previously described by Ono et al, 25 on the binding properties of Ku. These authors have shown by electrophoretic mobility shift assay that recombinant Ku binds only to linear double-stranded DNA, but not to supercoiled, nicked circular, or linear single-stranded DNA, and that neither subunit binds DNA by itself, suggesting that heterodimerization is essential for function. 25 It is also apparent that none of the deletions mutants obliterated Ku binding completely. However, the results suggest an interaction between Ku and an unidentified protein/s, and that the regulation of 15-LO-1 promoter by IL-4 and IL-13 is complex and may not be solely by Ku proteins. While our studies argue that Ku interacts with the DNA in a sequence-specific manner, we have not demonstrated (by UV-crosslinking) that Ku directly binds to the DNA.
Recently, however, Wang et al 26 have shown that two domains of p70 mediate DNA binding, one on the Cterminal and one on the N-terminal portion. The latter dimerizes with p80 in order to bind DNA, whereas the former is p80-independent. Interestingly, both the p80-dependent and the p80-independent DNA binding sites preferentially bound to DNA ends, suggesting a model in which a single Ku heterodimer may juxtapose two broken DNA ends physically, facilitating their rejoining by DNA ligases. Further, functions of Ku antigen have also been suggested in transcription, DNA replication, recombination, and repair, especially excision-repair. 18 Various transcription factors, including PSE, TREF, CTCBF, and CHBF, are considered to be identical or related to Ku antigen. These factors recognize the promoters of small nuclear RNA, transferrin receptor, colGenes and Immunity lagen IV, heat-shock protein 70, and HTLV-1 genes, respectively, in a sequence-specific manner and regulate the gene transcription (reviewed in Reeves et al). 17 Little similarity, however, seems to exist among the various Ku-binding DNA sequences reported so far, including the DP2 core element we identified here. One possible explanation for the lack of binding specificity is that different sequences may be recognized by Ku antigen in complexes with different proteins. 17 Our results with affinity column purification and Coomassie blue staining of isolated proteins showed that the fraction purified here as DP2 core binding protein contained no other detectable proteins. However, the association of other factors with Ku antigen or the presence of an as yet unidentified protein that may be homologous to Ku certainly cannot be ruled out.
Further, by immunoprecipitation experiments data (Figures 4-6 and -Ku70/80, while only a single protein in lower levels detectable by anti-Ku80. We have not identified and characterized these proteins so far. Again, the possibility of association of other factors with Ku antigen cannot be ruled out.
However, the data suggest that IL-4 and IL-13 have specific roles in the induction of Ku proteins, and that these interleukins possibly regulate protein-protein binding of Ku subunits and, hence, their DNA-binding properties-possibly accounting for their unequal potency in the upregulation of 15-LO-1 gene expression.
The biological significance of Ku expression has also been studied in aging and in cancer. Salminen et al, 27 have shown in WI-38 fibroblasts that replicative senescence and, to some extent, cellular quiescence, down-regulate the recognition system of DNA damage involving Ku autoantigens and DNA-PKcs. This could enhance the accumulation of DNA damage during aging. A role for Ku80 in autocrine and paracrine IL-6-mediated multiple myeloma cell growth and survival has been demonstrated by Teoh et al. 28 Their data suggest that CD40 ligand treatment of multiple myeloma cells with 5E2 mAbs induces a shift of Ku from the cytoplasm to the cell surface. Thus, Ku may function as an adhesion molecule that mediates homotypic adhesion of tumor cells, as well as heterotypic adhesion of tumor cells to bone marrow stromal cells and to human fibronectin.
Of relevance to our studies reported here, Serve et al 29 have demonstrated antiproliferative effects for IL-4 and IL-13 on breast cancer cell lines which express IL-13 binding sites, while Maini et al, 30 show that, IL-13 increased proliferation of all prostate cancer cell lines they studied. Similarly, immunoafinity-purified Ku protein used to screen (by quantitative immunoblot assay) sera from patients with systemic lupus erythematosus (SLE), scleroderma, myositis and Sjö gren's syndrome for anti-Ku antibodies indicated a strong correlation between anti-Ku antibodies and the class II HLA antigen DQw1, suggesting participation of major histocompatibility complex (MHC) genes in the mounting of the anti-Ku immune response. 31 It has also been shown previously that at least seven additional auto-epitopes (immunodominant epitopes) are present on the Ku particle, located on p70, p80, or both subunits, and that autoantibodies to p70, p80, and DNA are produced tandemly by patients with SLE. It was thus suggested that the multiple specificities of anti-Ku autoantibodies and the tandem production of antibodies to the various constituents of the Ku particle are consistent with a role of either 'molecular mimicry' or 'intermolecular help' in the generation of autoimmunity to this antigen. 32 Thus, it is possible that dysregulation of Ku function in SLE patients will render Ku unable to upregulate 15-LO-1, a molecule having an 'antiinflammatory' role. It is intriguing to speculate that dysregulation of this system may thus result in favoring 'pro-inflammatory' stimuli which, in turn, mediate the classical expression of SLE and other auto-immune disorders.
In conclusion, the results of the present study demonstrate that in human epithelial A549 cells, Ku appears to play a permissive role ('putative') in cytokine induction of 15-LO-1, likely by acting as a transcription factor. The findings may provide an important link between the established dysregulated function of Ku antigen in autoimmune diseases, such as systemic lupus erythematosus and thyroiditis, and the increasingly recognized 'antiinflammatory' role of 15-LO-1.
Experimental procedures
Materials
Tween 20, acrylamide, sodium dodecylsulphate (SDS), non-fat dry milk, low molecular weight protein markers, rabbit anti-sheep and donkey anti-rabbit IgG-horseradish peroxidase (HRP)-conjugate were purchased from BioRad. Murine monoclonal antibodies (mABs) specific for the human Ku antigen and control antibodies were purchased from either Oncogene Research Products (MA, USA) or Lab Vision Corp (CA, USA). Recombinant human IL-13 and −4 were purchased from Upstate Biotechnology (Lake Placid, NY, USA). The enhanced chemiluminescence (ECL) Western blotting detection system and polyvinylidene difluoride (PVDF) membranes (0.45 m) were purchased from Millipore (Bedford, MA, USA). The pGL2 and pRL-SV40 vector, reporter lysis buffer and dual-luciferase reporter assay kit were purchased from Promega (Madison, WI, USA). FuGENE TM 6 Transfection reagent, bovine serum albumin and phenylmethanesulfonyl fluoride was from Boehringer Mannheim (Mannheim, Germany). Penicillin, streptomycin, F-12 nutrient mixture (HAM) medium, and trypsin: EDTA were purchased from Life Technologies, Inc. Cell culture A549 lung carcinoma cells (alveolar type II epithelial cells) were obtained from ATCC and cultured in F-12 nutrient mixture (HAM) medium (Gibco-BRL, Rockville, MD, USA), containing 10% fetal bovine serum (FBS), 100 U of penicillin per ml, 100 g of streptomycin per ml, and 25 g of fungizone per ml in 5% CO 2 at 37°C. When the cells were 70-80% confluent, cytokines namely interleukin-13 (IL-13) and interleukin-4 (IL-4) at concentrations of ED 50 5 ng/ml and ED 50 0.2 ng/ml were added respectively. Controls were not treated with either cytokine.
Plasmids and site directed mutagenesis
To create mutations by site-directed mutagenesis in the DP2 sequence (Figure 1a) , we used QuickChange™ SiteDirected Mutagenesis kit (Stratagene). Plasmid used is similar to that described previously by Kelavkar et al. 16 A 605 bp 15-LO-1 promoter fragment, containing the DP2 binding site is cloned into a pGL-2 basic vector (Promega) and named LOPB-5. Briefly complementary oligonucleotides containing the desired mutation (indicated by lower case letters), flanked by unmodified nucleotide sequence were synthesized and reverse-HPLC purified. In a total of 50 l reaction system following components were added: 5 l of 10X reaction buffer, 20 ng of dsDNA template, 125 ng of each of the oligonucleotide primers, 1 l of dNTP mix and ddH 2 O to a final volume of 50 l.
One l of Pfu DNA polymerase (2.5 U/l) was then added, overlaid with 30 l of mineral oil and cycling was performed in a thermal cycler (9600 ABI) as follows: 1 cycle/95°C/30 s followed by 18 cycles at 95°C/30 s, 55°C/1 min, 68°C/13 min. Following this reaction, tubes were placed on ice for 2 min and then 1 l of DpnI restriction enzyme (10 U/l) added. After gentle mixing, these reaction tubes were incubated further at 37°C for 1 h. Following this incubation, 1 l of reaction mixture from individual tubes was used to transform the Epicurian Coli XL1-Blue supercompetant cells. The cells were plated on Luria agar plates containing 50 g/ml ampicillin. Ten individual clones were picked from plates and sequenced to insure correct sequence of the desired insert. Following are names and sequences of the oligonucleotides used to make the desired mutants:
Before selection of the targeted regions, the sequences were screened for uniqueness in all non-redundant GenBank CDS translations + Protein Data Bank (PDB) + SwissProt + Protein Identification Resource Database (PIR) using Blast and Transfac version 3.5 for identifying potential transcription factor binding sites. They were also were tested for lack of internal secondary structure or pairing using Mulfold. 33 
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Transient transfections and dual luciferase assays Transient transfections were carried out using luciferase reporter construct (promoter fragment cloned into pGL2-basic (Promega). Cells were plated at 40% confluency in 12-well plates. After 24 h, the plasmid DNA (1 g) [LOPB5: containing DP2 binding site (Figure 1 ) and, mutants: DP3 through DP6], were individually co-transfected with co-reporter pRL-SV40 vector promoter upstream of Rluc (Promega) into A549 cells by FuGENE™ 6 Transfection reagent (Boehringer Mannheim). The pRL-SV40 vector is used to monitor transfection efficiency. The cells were grown for 24 h before being harvested for assays. For assays, the cells were trypsinized, washed thrice with phosphate buffered saline (PBS). The cell extracts were prepared with 400 l reporter lysis buffer (Promega), clarified by centrifugation at 20 000 g at 4°C for 2 min, and the supernatant transferred to a new tube. The clarified supernatants were individually analyzed for dual-luciferase reporter assays (100 l) using a luminometer with autoinjector (Turner design), as described by the manufacturer (Promega). Experiments were performed in duplicate or triplicate.
Monoclonal antibodies
The isotypes and specificities of murine monoclonal antibodies (mABs) specific for the human Ku antigen and control antibodies are as follows: 162, IgG2a specific for p70/p80 dimer (unreactive with free p70 or p80); 111, IgG1 specific for human p80 (amino acids 610-705); N3H10, IgG2b specific for human p70 (amino acids 506-541); 265-F4, Control antibody-IgG1 specific for Hamster p170/p-Glycoprotein/MDR (does not react with human).
Extraction of proteins, protein assay, gel mobility shift and supershift assays and magnetic bead purification of DNA binding factors Proteins from whole-cell extracts of A549 cells grown for 24 h (control and experimentally grown) were prepared according to the method described by Dignam et al. 34 Protein concentrations in whole-cell extracts were determined by protein assay kit (Bio-Rad). Gel shift assay was performed as described by Austin et al, 35 using DP2 containing oligonucleotide (control) and mutant oligonucleotides that are described previously in this section. Briefly, 1 mg of annealed oligonucleotides were end-labeled with [␥-32 P] ATP and T4 polynucleotide kinase, purified by gel filtration on Sephadex G25, separated on a 10% polyacrylamide gel, and then eluted from the gel. Binding reactions were conducted using the respective radiolabeled DNA fragments (2 × 10 4 cpm, 40 fmol for each reaction) in 20 l of binding buffer (20 mm Hepes, pH 7.9, 1 mm DTT, 5 mm EDTA, 10% glycerol and 150 mm NaCl) at 22°C for 30 min. For supershift experiments, mABs (1 l of ammonium sulfate precipitated ascitic fluid 200 g/ml) were added to the binding mixture 5 min after adding probe and incubated for an additional 30 min at 22°C before electrophoresis. Whenever added, 3 pmol competitor (unlabeled fragment) was used. Nonspecific oligonucleotide (control): TGF␤-1, ATCCGT CTGCAGCGTCTTGCCCAATGTTCTGACGTATT was used in competition experiments described earlier 16 and hence not included in the gel-shift experiments described in this paper. The reactions products were run on a 13% nondenaturing polyacrylamide gel in 0.5X TBE buffer at 100 V for 4 h. The gel was dried on a gel dryer and then exposed to X-ray film overnight at −70°C with an intensifying screen.
The transcription factor binding to the DP2 core element was purified by affinity chromatography described previously by Kroeger and Abraham, 36 with slight modifications, using biotin labeled doublestranded oligonucleotides immobilized on streptavidincoated Dynabeads (Dynal, USA). The scheme is described in Figure 1b . Briefly, prior to loading, Dynabeads were washed twice in 1X coupling buffer [CB] (1X CB; 2 m NaCl, 10 mm Tris, pH 8.0, 1 mm EDTA) and then incubated with DNA at 100 pmol oligonucleotide/mg beads, at room temperature for 30 min. Beads were then concentrated using magnetic particle concentrator (MPC, Dynal) for 1-2 min. Protein was isolated from Ϸ100 mg crude extracts from individually-treated cells grown in a total of 50 flasks respectively. Crude whole-cell extracts (Ϸ2 mg), in 500 l binding buffer was used for every cycle and a total of 25 cycles were performed as described in Figure 1b to obtain saturated binding of protein to DNA. Incubations were carried out in the absence of nonspecific competitor DNA [poly(dI-dC)]. Following binding, unbound proteins were removed by concentrating the beads and washing once for 5 min on ice with 500 l binding buffer. A second wash with binding buffer containing 5 g of poly(dI-dC) and then a third wash with binding buffer alone were performed to remove proteins that had bound non-specifically. Immunoprecipitation and Western blotting of the flow-through fractions with Ku antibody mixture was performed to ensure saturated binding of the protein (data not shown). Specific DNA binding proteins were then eluted from the beads by incubating in 20 l binding buffer containing 1 m KCl for 60 min on ice. These binding proteins were then concentrated by ultrafiltration (Amicon YM10 membrane) and stored in liquid nitrogen until further use. 4 and either anti-Ku70, anti-Ku80, Ku70/80 or control IgG1 antibodies at a final concentration of 10 g/ml were used. Following electroporation, cells were incubated for an additional 30 min at 37°C and 5% CO 2 , washed once with serum-free F-12 nutrient mixture (HAM) medium, and then cultured in HAM medium with serum during the stimulation with IL-13 and IL-4. /mmol) , from NEN Life Science products, in 2 ml of methioninefree medium, containing 4 mm sodium pyruvate and 2 mm glutamine. Subsequent to a pulse of 6 h duration, the medium was removed and replaced with 3 ml of F-12 medium containing 2 mm methionine with a chase for 24 h. The effects of cycloheximide was evaluated by including this inhibitor in the medium at concentrations of 150 g/ml, for a 30-min incubation before the addition of the radioisotope; the inhibitors were kept in the medium during a 6 h pulse but omitted during 10 h chase.
Electroporation
Radiolabeling of cultured cells
At the end of the incubations, the plates were washed with ice-cold PBS (0.05 m sodium phosphate buffer, pH 7.4, containing 0.15 m NaCl), containing unlabeled substrate (2 mm methionine). The cells were then harvested by centrifugation after scraping into cold PBS containing 1 mm phenylmethylsulfonyl fluoride and aprotinin (10 units/ml). Subsequently, the cells were submitted to lysis at 4°C with a lysis buffer consisting of 50 mm Tris/HCl, pH 7.6, 300 mm NaCl, 0.5% (v/v) Triton X-100, 5 mm EDTA, 10 g/ml leupeptin, 10 units/ml aprotinin, 10 mm iodoacetamide, and 2 mm phenylmethylsulfonyl fluoride followed by centrifugation at 14 000 rpm in an Eppendorf microcentrifuge for 15 min. After the addition of 300 l of the lysis buffer, the fractions from radiolabeled cells were analyzed by immunoprecipitation followed by polyacrylamide gel electrophoresis (PAGE.).
Immunoprecipitation
Antibody-coated beads were prepared by gently shaking for 2 h at room temperature 30 l of a 1:1 suspension of PBS-washed hybrid protein A/G-Agarose beads (Pierce) with 2 g of monoclonal antibodies, followed by washing with PBS and PBS-containing 0.1% (w/v) bovine serum albumin. Aliquots of cell lysates, precleared by centrifugation at 14 000 g for 15 min in an Eppendorf microcentrifuge, were then added to the coated beads and shaken for 2 h at room temperature in a total volume of 400 l of lysis buffer containing a mixture of protease inhibitors. After pelleting by centrifugation (800 g for 10 min at 4°C), the beads were washed four times with 500 l of a solution containing 50 mm Tris/HCl, pH 7.6, 300 mm NaCl, 0.1% (v/v) Triton X-100, 0.02% SDS, and protease inhibitors. Protein was then released from the washed beads by boiling for 5 min in PAGE sample buffer containing 1% SDS and 2% (v/v) 2-mercaptoethanol.
SDS-PAGE and Western blotting
For detection of Ku antigen; 25 g protein sample of whole-cell extract from control and experimentally grown A549 (2 × 10 6 cells) was mixed with loading buffer boiled for 5 min, and then loaded onto a 10% polyacrylamide gel containing 0.1% SDS. The gel was run at 200 V for 40 min. The separated proteins were Coomassie blue stained or transferred onto individual PVDF membranes by electroblotting. Ponceau S staining of the blots was conducted to ensure equivalent loading. After being blocked with 5% non-fat dry milk in PBS, the nitrocellulose membranes were incubated with their respective antibodies (1:250 dilution) for 1 h at RT. Following incubation with goat anti-mouse IgG peroxidase second antibody (1:5000 dilution), the proteins were visualized by using the Luminol/Enhancer (ECL) solutions as described by the manufacturer.
Isolation and analysis of mRNAs
The A549 cells were harvested, and RNA was extracted for semiquantitative-RT-PCR. Briefly, Reverse-transcriptase (RT)-PCR of 15-Lipoxygenase-1 mRNA and GAPDH in A549 cells was performed using total RNA. One g was reverse-transcribed in 45 l of 50 mm Tris/HCl buffer, pH 8.2, containing 8 mm MgCl 2 , 30 mm KCl, 1 mm dithiothreitol, 100 g/ml BSA, 30 units of RNase inhibitor, 0.166 mm of each dNTP, 150 pmol of oligo(dT) primer and 15 units of reverse transcriptase according to the manufacturers instructions (PerkinElmer). Samples were heated to 95°C for 10 min. For 15-Lipoxygenase-1, the PCR primers (5Ј-GAGAGTT GACTTTGAGGTTTCGC-3Ј and 5Ј-CAGCCACGTCT GTCTTATAGTGG-3Ј) were selected from regions displaying minimal sequence similarity to the sequences of human 12-lipoxygenase and leucocyte 5-lipoxygenase, and proved to be not suitable for the amplification of the human cDNAs of these two enzymes.
The primers for the PCR of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were 5Ј-TCGGAGT CAACGGATTTGGTCGTA-3Ј and 5Ј-ATGGACTGTG GTCATGAGTCCTTC-3Ј. After initial denaturation for 3 min at 94°C, PCR was carried out for 23 cycles. Each cycle consisted of a denaturing period (40 s at 94°C), an annealing phase (30 s at 60°C for GAPDH and at 62°C for 15-Lipoxygenase-1) and an extension period (30 s at 72°C for both primer sets). The reaction mixture was 10 mm Tris/HCl buffer, pH 8.3, containing 50 mm KCl, 2 mm MgCl 2 , 0.1 mg/ml gelatine, 6 pmol of primer sets, 100 m of each dNTP, 100 g/ml BSA and 2.5 units of Taq DNA polymerase. PCR products were separated by 2% agarose gel electrophoresis. For semiquantification, DNA was stained with ethidium bromide and analyzed densitometrically.
